Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BAYER AG
06/17Bayer to Continue to Work With Curevac After Covid-19 Study Disappointment
DJ
06/14DGAP-PVR  : Bayer Aktiengesellschaft: Release -2-
DJ
06/14BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
06/13BAYER  : Swiss reject law to help country meet Paris carbon emissions goal
RE
06/12BAYER  : Swiss voters to decide on pesticides ban, terrorism law and COVID-19 ai..
RE
06/10Mexico stalling GMO corn permits ahead of ban, says top farm lobby
RE
06/10Mexico stalling GMO corn permits ahead of ban, says top farm lobby
RE
06/10DGAP-PVR : Bayer Aktiengesellschaft: Release -2-
DJ
06/10BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
06/09GSK consumer arm confident that growth, cash flow will help with debt
RE
06/09BAYER  : BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase ..
AQ
06/09BAYER  : to advance two first-of-its-kind cell and gene therapies for Parkinson'..
AQ
06/08BAYER  : to advance two first-of-its-kind cell and gene therapies for Parkinson'..
PU
06/08BAYER  : Unveils Two New Clinical Trials Targeting Parkinson's Disease
MT
06/08Bayer Advancing Cell, Gene Therapies for Parkinson's Disease
DJ
More most relevant news
All news about BAYER AG
06/18PRESS RELEASE  : BioNTech Announces First Patient Dosed in Phase 2 Clinical Tria..
DJ
06/18CureVac Could Allow Manufacturing Partners To Produce Rival Vaccines
MT
06/17SECTOR UPDATE : Health Care Stocks Add to Afternoon Gains
MT
06/17CureVac may let contractors make rival vaccines if own shot fails -CEO
RE
06/17SECTOR UPDATE : Health Care Stocks Maintaining Modest Thursday Advance
MT
06/17CureVac may let contractors make rival vaccines if own shot fails - CEO
RE
06/17CUREVAC N  : Reports Disappointing Study Results for COVID-19 Vaccine, Driving S..
MT
06/17Bayer to Continue to Work With Curevac After Covid-19 Study Disappointment
DJ
06/16CUREVAC N  : COVID-19 Vaccine Only 47% Effective in Mid-Stage Study
MT
06/16CureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
RE
More news
News in other languages on BAYER AG
06/18EM : Kroatien nach Remis gegen Tschechien unter Druck
06/18BAYER  : Glyphosat-Studie stützt Bayer - EU-Verbot wackelt
06/18BAYER  : Astepro va être vendu sans ordonnance aux USA
06/18PTA-DD  : Bayer Aktiengesellschaft: Mitteilung über Eigengeschäfte von Führungsk..
06/18GlobeNewswire/BioNTech gibt Dosierung des ersten Patienten mit fortgeschritte..
06/17CORONA-BLOG/Portugal erlässt kurzfristig neue Corona-Einschränkungen für Liss..
06/17CORONA-BLOG/Deutschland hebt Einreisebeschränkungen für Geimpfte aus Drittsta..
06/17CORONA-BLOG/Neue Corona-Varianten hinter Anstieg der Infektionszahlen in Mosk..
06/17CORONA-BLOG/Erstmals seit Februar mehr als 10.000 Neuinfektionen in Großbrita..
06/17MÄRKTE EUROPA/SMI steigt erstmals über 12.000 Punkte - Curevac schwach
More news
Analyst Recommendations on BAYER AG
05/27BAYER AG  : Bryan Garnier sticks Neutral
MD
05/27BAYER AG  : Kepler Cheuvreux maintains a Buy rating
MD
05/27BAYER AG  : Receives a Buy rating from NorldLB
MD
05/27BAYER AG  : JP Morgan reiterates its Buy rating
MD
05/27BAYER AG  : Warburg Research sticks Neutral
MD
More recommendations
Press releases
06/14BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
06/10BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpH..
EQ
06/09BAYER  : BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase ..
AQ
06/09BAYER  : to advance two first-of-its-kind cell and gene therapies for Parkinson'..
AQ
06/08BAYER  : to advance two first-of-its-kind cell and gene therapies for Parkinson'..
PU
More press releases
Upcoming event on BAYER AG